Aithexo Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Dadri, Uttar Pradesh, India, established in 2023.
2023 Dadri, Uttar Pradesh, India Active
Last Updated:
Access Report
About Aithexo Pharmaceuticals Llp

Aithexo Pharmaceuticals Llp, a active limited liability partnership, was established on 25 May 2023 in Dadri, Uttar Pradesh, India. Engaging in commission trade within the business services sector, it holds LLPIN: ACB-3488. Registered under ROC Roc Kanpur. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Sumit Pratap Singh (Designated Partner), Soni Singh (Designated Partner), Bhanupratap Singh (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at S 024,Site4,Kasna Greater, Noida, Shopping Plaza, Dadri, Uttar Pradesh, 201310.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACB-3488

  • Incorporation Date

    25 May 2023

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 2 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Aithexo Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aithexo Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aithexo Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Sumit Pratap Singh Designated Partner 25 May 2023 Current
Soni Singh Designated Partner 25 May 2023 Current
Bhanupratap Singh Designated Partner 25 May 2023 Current
Surekha Yadav Designated Partner 25 May 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aithexo Pharmaceuticals Llp.

Enhance accessibility to Aithexo Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aithexo Pharmaceuticals Llp revenue growth over time
Aithexo Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aithexo Pharmaceuticals Llp?

Unlock access to Aithexo Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aithexo Pharmaceuticals Llp?

Unlock and access historical data on people associated with Aithexo Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aithexo Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aithexo Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aithexo Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Aithexo Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Aithexo Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    Sumit Pratap Singh was appointed as a Designated Partner was appointed as a Designated Partner on 25 May 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Soni Singh was appointed as a Designated Partner was appointed as a Designated Partner on 25 May 2023 & has been associated with this company since 2 years 8 months . was documented.

  • Director Appointment

    Progress on Bhanupratap Singh was appointed as a Designated Partner was appointed as a Designated Partner on 25 May 2023 & has been associated with this company since 2 years 8 months . was documented.

  • Director Appointment

    Progress on Surekha Yadav was appointed as a Designated Partner was appointed as a Designated Partner on 25 May 2023 & has been associated with this company since 2 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aithexo Pharmaceuticals Llp?

The LLPIN of Aithexo Pharmaceuticals Llp is ACB-3488.

Where is Aithexo Pharmaceuticals Llp headquartered?

Aithexo Pharmaceuticals Llp is headquartered at S 024,Site4,Kasna Greater, Noida, Shopping Plaza, Dadri, Uttar Pradesh, 201310.

When was Aithexo Pharmaceuticals Llp incorporated?

Aithexo Pharmaceuticals Llp was incorporated on 25 May 2023.

Who are the current directors of Aithexo Pharmaceuticals Llp?

The current directors of Aithexo Pharmaceuticals Llp are

What is the primary industry of Aithexo Pharmaceuticals Llp?

The primary industry of Aithexo Pharmaceuticals Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available